Relmada Therapeutics, Inc.

News

Latest Press Releases, Articles & Media Resources

Press Releases

March 24, 2020
Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development

NEW YORK, March 24, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointment of Judy Caron, Ph.D., as Vice President of Drug Development.  Dr. Caron has 30 years of experience in biopharmaceutical development. Dr. Caron joins Relmada from Neurana… Read More »

More Press Releases